# Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

> **NCT00243243** · PHASE3 · COMPLETED · sponsor: **United States Army Institute of Surgical Research** · enrollment: 20 (actual)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Recombinant Factor VIIa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00243243
- **Lead sponsor:** United States Army Institute of Surgical Research
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243243, "Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00243243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*